Details of the Drug

General Information of Drug (ID: DMMACXS)

Drug Name

VLA15

Indication

Disease Entry	ICD 11	Status	REF
Lyme disease	1C1G	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03970733) Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis. U.S. National Institutes of Health.